WASHINGTON — The Biden administration is making its opening offers to pharmaceutical companies in its brand-new Medicare drug price negotiation program on Thursday, administration officials said. And that’s about all they said.
The offers will not be made public unless a manufacturer chooses to publicly disclose information about the talks, a senior administration official said. Companies have until March 2 to either accept the government’s offer or propose a counteroffer. The Biden administration will publish the final prices by Sept. 1 of this year after the negotiation process ends.
advertisement
The negotiated prices won’t take effect until 2026.
Get unlimited access to award-winning journalism and exclusive events.
Subscribe Log In
Previous article：
What nurses really want: sufficient staffing for patient care
Next article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： 23andMe had bad news about my health. I wish a person had delivered it
.png?upscale=true&width=1212&upscale=true&name=vTFET-vaccine-makers-surge-on-bird-flu-fears(3).png)